| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.7 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.7 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.7 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | 0.016 | 0.7 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | -0.017 | 0.8 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | -0.017 | 0.8 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |